An analysis of the prevalence of HER2 and KRAS mutations, and ALK rearrangements and clinical outcomes in Cancer and Leukemia Group B [CALGB (Alliance)] trial 30406 in advanced non-small cell lung cancer (NSCLC).


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Stinchcombe, T; Sholl, LM; Wang, XF; Gu, L; Socinski, MA; Rodig, SJ; Capelletti, M; Crawford, J; Edelman, MJ; Villalona-Calero, MA; Kratzke, RA; Vokes, EE; Miller, VA; Janne, PA

Published Date

  • May 20, 2013

Published In

Volume / Issue

  • 31 / 15

Published By


  • 1

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Conference Location

  • Chicago, IL

Conference Start Date

  • May 31, 2013

Conference End Date

  • June 4, 2013